Arcturus Therapeutics Holdings ARCT
$ 18.06
-3.14%
Quarterly report 2024-Q3
added 11-07-2024
Arcturus Therapeutics Holdings Financial Statements 2011-2024 | ARCT
Annual Financial Statements Arcturus Therapeutics Holdings
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
968 M | 962 M | 688 M | 1.47 B | 125 M | 50.3 M | 24.7 M | 28.7 M | 111 M | 84.4 M | 223 M | 20.7 M | - |
Shares |
26.6 M | 26.4 M | 26.3 M | 20.3 M | 12.1 M | 10.1 M | 3.09 M | 3.94 M | 3.09 M | 1.95 M | 1.45 M | 1.59 M | - |
Historical Prices |
36.4 | 36.4 | 26.1 | 72.5 | 10.3 | 5 | 7.76 | 7.35 | 35.8 | 43.2 | 153 | - | - |
Net Income |
-29.7 M | 9.35 M | -204 M | -72.1 M | -26 M | -21.8 M | -10.9 M | -24.6 M | -19.4 M | -32.8 M | -10.5 M | -1.58 M | -3.93 M |
Revenue |
167 M | 206 M | 12.4 M | 9.54 M | 20.8 M | 15.8 M | 13 M | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 9.54 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-78.2 M | 12.2 M | -203 M | -71.5 M | -25.5 M | -21.8 M | - | - | - | - | - | - | - |
Interest Expense |
16.6 M | -420 K | -1.92 M | -361 K | -446 K | 328 K | - | - | - | - | - | - | - |
EBITDA |
-75.2 M | 13.7 M | -202 M | -70.6 M | -24.8 M | -21.2 M | -10.1 M | -25.1 M | -19.6 M | -33 M | -10.3 M | -1.49 M | -3.88 M |
Operating Expenses |
245 M | 194 M | 215 M | 81.1 M | 46.3 M | 37.6 M | 23.5 M | 25.2 M | 19.7 M | 33.1 M | - | - | - |
General and Administrative Expenses |
52.9 M | 46.1 M | 41.5 M | 23.2 M | 12.7 M | 20.6 M | 7.57 M | 5.36 M | 4.99 M | 5.84 M | 3.22 M | 683 K | 2.08 M |
All numbers in USD currency
Quarterly Income Statement Arcturus Therapeutics Holdings
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
27.1 M | 27 M | 26.9 M | 26.8 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 26.5 K | 26.4 K | 26.4 K | 26.4 M | 26.3 M | 26.3 M | 26.2 M | 24.9 M | 22.9 M | 18.8 M | 14.5 M | 14.5 M | 13.2 M | 10.4 M | 10.1 M | 10.7 M | 10.1 M | 10.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-6.9 M | -17.2 M | -26.8 M | - | -16.2 M | -52.6 M | 50.8 M | - | -35.3 M | -21.6 M | -51.2 M | -38.7 M | -54.1 M | -54.6 M | -56.3 M | -31.1 M | -21 M | -10.3 M | -9.78 M | -11 M | -7.43 M | -685 K | -6.88 M | - | -4.25 M | -9.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
41.7 M | 49.9 M | 38 M | - | 45.1 M | 10.5 M | 80.3 M | - | 13.4 M | 27.1 M | 5.24 M | 5.79 M | 2.44 M | 2 M | 2.13 M | 2.24 M | 2.33 M | 2.32 M | 2.65 M | 2.97 M | 3.32 M | 10.2 M | 4.35 M | - | 3.42 M | 2.39 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.7 M | -21.1 M | -30.4 M | - | -19.3 M | -55.4 M | 14.8 M | - | -36.8 M | -22.1 M | -50.4 M | -37.6 M | -53.8 M | -53.7 M | -57.7 M | -31.1 M | -20.9 M | -10 M | -9.46 M | -10.8 M | -7.62 M | -572 K | -6.51 M | - | -4.36 M | -10.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
3.82 M | 4.15 M | 4.02 M | - | 3.98 M | 3.25 M | 2.48 M | - | -321 K | -560 K | -564 K | - | -519 K | -520 K | -358 K | - | -66 K | -121 K | -152 K | - | -120 K | -113 K | -88 K | - | 150 K | 169 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-9.84 M | -20.2 M | -29.5 M | - | -18.5 M | -54.7 M | 15.3 M | - | -36.4 M | -21.7 M | -50.2 M | -37.6 M | -53.5 M | -53.4 M | -57.4 M | -31.1 M | -20.7 M | -9.84 M | -9.28 M | -10.8 M | -7.42 M | -372 K | -6.34 M | - | -4.16 M | -9.97 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
52.4 M | 71 M | 68.4 M | - | 64.5 M | 65.9 M | 65.5 M | - | 50.2 M | 49.2 M | 55.6 M | - | 56.3 M | 55.7 M | 59.8 M | - | 23.3 M | 12.4 M | 12.1 M | - | 10.9 M | 10.7 M | 10.9 M | - | 7.78 M | 12.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
13.3 M | 12.3 M | 14.9 M | - | 13.4 M | 13.2 M | 13.8 M | - | 12.5 M | 11 M | 10.7 M | 10.8 M | 10.9 M | 10 M | 9.74 M | 9.03 M | 5.57 M | 4.42 M | 4.19 M | 1.79 M | 3.88 M | 3.46 M | 3.53 M | - | 3.81 M | 8.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency